Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
DCT Board Approves Phase 2/3 Studies Of LAK-IL-2
This article is from
The Cancer Letter
archive.
Vol. 12 No. 07 | February 14, 1986
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
President Obama Signs FDA User Fee Act Into Law
July 13, 2012
TCL Archive
Gemcitabine Improves DFS In Resected Pancreatic Cancer
June 24, 2005
TCL Archive
AACR, Kellogg’s Co. Sponsor Award
January 5, 1996
TCL Archive
Long-Term Remissions Shown With Chemo Plus Radiation
September 29, 2006
TCL Archive
Dendritic Cell Vaccine Increases PFS in Phase II Clinical Trial
December 27, 2013
TCL Archive
NCI Is Convinced It Has Isolated Human Cancer Virus
February 14, 1975